Cardio Diagnostics Holdings Bilan de santé

Santé financière contrôle des critères 4/6

Cardio Diagnostics Holdings possède un total de capitaux propres de $3.7M et une dette totale de $0.0, ce qui porte son ratio d'endettement à 0%. Son actif total et son passif total sont $4.5M et de $795.3K.

Informations clés

Ratio d'endettement

US$0

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	US$1.98m
Fonds propres	US$3.69m
Total du passif	US$795.28k
Total des actifs	US$4.48m

Mises à jour récentes de la santé financière

We Think Cardio Diagnostics Holdings (NASDAQ:CDIO) Can Afford To Drive Business Growth

Mar 01

Companies Like Cardio Diagnostics Holdings (NASDAQ:CDIO) Are In A Position To Invest In Growth

Nov 02

Recent updates

We Think Cardio Diagnostics Holdings (NASDAQ:CDIO) Can Afford To Drive Business Growth

Mar 01

Companies Like Cardio Diagnostics Holdings (NASDAQ:CDIO) Are In A Position To Invest In Growth

Nov 02

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de CDIO ( $2.6M ) dépassent ses passifs à court terme ( $308.7K ).

Passif à long terme: Les actifs à court terme de CDIO ( $2.6M ) dépassent ses passifs à long terme ( $486.6K ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: CDIO est sans dette.

Réduire la dette: CDIO n'avait aucune dette il y a 5 ans.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: CDIO dispose de moins d'un an de piste de trésorerie sur la base de son flux de trésorerie disponible actuel.

Prévisions de trésorerie: CDIO dispose de moins d'un an de marge de trésorerie si le flux de trésorerie disponible continue de diminuer à un taux historique de 51.6 % chaque année

Cardio Diagnostics Holdings Bilan de santé

Santé financière contrôle des critères 4/6

Informations clés

Mises à jour récentes de la santé financière

Cardio Diagnostics Holdings Receives Written Notice from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement Under Nasdaq Listing Rule 5550(a)(2)

Cardio Diagnostics Holdings Receives an Email Notice from the Listing Qualifications Staff of the Nasdaq Stock Market

Cardio Diagnostics Holdings Receives a Written Notice from the Nasdaq Stock Market

We Think Cardio Diagnostics Holdings (NASDAQ:CDIO) Can Afford To Drive Business Growth

Companies Like Cardio Diagnostics Holdings (NASDAQ:CDIO) Are In A Position To Invest In Growth

Recent updates

New major risk - Shareholder dilution

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Price target decreased by 57% to US$2.00

Cardio Diagnostics Holdings, Inc., Annual General Meeting, Nov 15, 2024

Consensus revenue estimates decrease by 89%, EPS upgraded

New major risk - Market cap size

Consensus revenue estimates fall by 16%

Cardio Diagnostics Holdings Receives Written Notice from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement Under Nasdaq Listing Rule 5550(a)(2)

New major risk - Financial position

Cardio Diagnostics Holdings, Inc. Announces the Availability of its Clinical Tests at Family Medicine Specialists' Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois

Cardio Diagnostics Holdings, Inc. Announces Publication of Study Showing That Its PrecisionCHD Test Could Save Health Insurers over $113 Million Annually

Price target increased by 33% to US$8.00

Consensus EPS estimates upgraded to US$0.43 loss, revenue downgraded

Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 At the American College of Cardiology’s 73rd Annual Scientific Session

Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease

Cardio Diagnostics Holdings, Inc. Expands Heartrisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout

Consensus revenue estimates decrease by 48%, EPS upgraded

Cardio Diagnostics Holdings Unveils Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk

Cardio Diagnostics Holdings, Inc. Appoints Paul F. Burton as Independent Director, Chair of Nominating and Corporate Governance Committee and Member of Audit Committee

Cardio Diagnostics Holdings, Inc. Elects Paul F. Burton as Director

American Medical Association Is Reviewing Cardio Diagnostics Holdings, Inc.'s Integrated Epigenetic-Genetic Cardiovascular Medicine Tests for CPT PLA Codes

Consensus revenue estimates increase by 38%

Cardio Diagnostics Holdings Receives an Email Notice from the Listing Qualifications Staff of the Nasdaq Stock Market

Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with Precisionchd Test, Published in the Journal of the American Heart Association

New major risk - Shareholder dilution

Cardio Diagnostics Holdings, Inc., Annual General Meeting, Dec 04, 2023

Cardio Diagnostics Holdings, Inc., Annual General Meeting, Dec 04, 2023

Cardio Diagnostics Holdings Receives a Written Notice from the Nasdaq Stock Market

New major risk - Market cap size

Cardio Diagnostics Holding, Inc’S Actionable Clinical Intelligencetm (Aci) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management

We Think Cardio Diagnostics Holdings (NASDAQ:CDIO) Can Afford To Drive Business Growth

High number of new and inexperienced directors

No independent directors

Companies Like Cardio Diagnostics Holdings (NASDAQ:CDIO) Are In A Position To Invest In Growth

No independent directors

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines